drugset / Trial / NCT03845894

Interscalene Block With Liposomal Bupivacaine vs. Interscalene Block With Bupivacaine and Adjuvants

NCT03845894

Phase 4 Terminated 25 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether the use of plain bupivacaine with common adjuvants for interscalene block (ISB) provides non-inferior analgesic results compared to the use of liposomal bupivacaine for ISB, in patients undergoing total shoulder arthroplasty.

Timeline

Start
2020-03-03
Primary completion
2022-06-25
Completion
2022-06-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified Other
Comparator Buprenorphine Other / unclassified Other
Comparator Clonidine Other / unclassified Other
Comparator Dexamethasone Small molecule Other
Comparator Epinephrine Other / unclassified Other

Indications

No indication recorded.